PAOG (PAO Group) Marketable Securities: $0.00 Mil (As of . 20)


What is PAO Group Marketable Securities?

PAO Group PAOG -20.00% Marketable Securities is $0.00 Mil as of . 20.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. PAO Group's Marketable Securities for the quarter that ended in . 20 was $0.00 Mil.

PAO Group  (OTCPK:PAOG) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

PAO Group Marketable Securities Related Terms

PAO Group Marketable Securities Historical Data

* Premium members only.

The historical data trend for PAO Group's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PAO Group Marketable Securities Chart

PAO Group Annual Data
Trend
Marketable Securities

PAO Group Quarterly Data
Marketable Securities

PAO Group Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
PAO Group (PAOG) has a Marketable Securities of $0.00 Mil as of . 20. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PAO Group and its competitors.
Is PAO Group's Marketable Securities too high?
PAO Group's current Marketable Securities is $0.00 Mil.
How does PAO Group's Marketable Securities compare to MIHI and LMNK?
PAO Group's Marketable Securities of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PAO Group and its competitors. PAO Group's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PAO Group stock overvalued right now?
PAO Group (PAOG) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For PAO Group (PAOG), the current Marketable Securities is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PAO Group Business Description

Address 3535 Executive Terminal Drive, Suite 110, Henderson, NV, USA, 89052
PAO Group Inc. is a United States-based holding company. It seeks to develop, acquire, partner with, or participate in companies and concepts in the development and launch of alternative medicine clinics focused on non-traditional patient care solutions. The range of treatment solutions includes cannabis, acupuncture, chiropractic, biofeedback, and other solutions, depending on patient needs.